Angie Ramírez Ramírez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Angie Ramírez Ramírez has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Jose Gustavo Ramos
Department of Urology Oncology, National Cancer Institute of Colombia, Bogotá, Colombia
2 shared publications - Carlos Riveros
Department of Urology, Houston Methodist Hospital, Houston, TX 77030, USA
1 shared publication - Cristina Dominguez
Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, Colombia
1 shared publication - Jorge Forero Muñoz
Unidad Funcional Urología, Instituto Nacional de Cancerología, Bogotá, D.C., Colombia
1 shared publication - Juan P. Rojas-Manrique
Urologic Oncology, Instituto Nacional de Cancerologia, Bogotá, COL
1 shared publication - Luis Miguel Becerra
Urología Oncológica, Universidad Militar Nueva Granada, Bogotá, D.C., Colombia
1 shared publication
Latest Publications
- Open Access
- 30 December 2022
- Published by Instituto Nacional de Cancerologia in Revista Colombiana de Cancerología
- Vol. 26 (4) , 442-47
Tumores renales de pacientes con riñones en herradura: reporte de 2 casos clínicos
El riñón en herradura (RH) es la anomalía congénita de fusión renal más común. La incidencia del tumor de células renales en riñón en herradura es similar a la de los pacientes con riñones de estructura normal; en cambio, el riesgo de desarrollar cáncer de células transicionales aumenta entre 2 a 6 veces. La presencia de cualquier malformación renal puede cambiar el plan de tratamiento quirúrgico y se busca realizar una cirugía con preservación de órgano. Se describen 2 casos clínicos de tumores (carcinoma renal de células claras y tumor urotelial) en riñones en herradura llevados a heminefrectomía radical abierta y laparoscópica.
- 30 December 2022
- Published by Instituto Nacional de Cancerologia in Revista Colombiana de Cancerología
- Vol. 26 (4) , 442-47
Open AccessTumores renales de pacientes con riñones en herradura: reporte de 2 casos clínicos
El riñón en herradura (RH) es la anomalía congénita de fusión renal más común. La incidencia del tumor de células renales en riñón en herradura es similar a la de los pacientes con riñones de estructura normal; en cambio, el riesgo de desarrollar cáncer de células transicionales aumenta entre 2 a 6 veces. La presencia de cualquier malformación renal puede cambiar el plan de tratamiento quirúrgico y se busca realizar una cirugía con preservación de órgano. Se describen 2 casos clínicos de tumores (carcinoma renal de células claras y tumor urotelial) en riñones en herradura llevados a heminefrectomía radical abierta y laparoscópica.
- Open Access
- 24 September 2019
- Published by Springer Nature in Cureus
- Vol. 11 (9) , e5740
Clinical and Histopathological Characteristics of Prostate Cancer Patients Taken to Palliative Transurethral Prostate Resection
In prostate cancer (PCa) patients who have been treated with radiotherapy and/or androgen deprivation therapy (ADT), palliative transurethral resection of the prostate (TURP) is a management option in the presence of lower urinary tract symptoms (LUTS). The present work seeks to describe the clinical and histopathological characteristics of patients with PCa taken to palliative TURP. An observational, descriptive and retrospective study of patients with PCa who underwent palliative TURP for the relief of obstructive urinary symptoms at an oncology reference center between January 2006 and June 2014 was performed. Among the included patients were those with localized PCa treated with radiotherapy and those with advanced PCa with or without metastasis who had previously received ADT. Sixty-six patients with a diagnosis of PCa taken to palliative RTUP were identified. Fifty patients (78.4%) were received some type of ADT, seven patients (10.7%) received curative radiotherapy along with adjuvant ADT, five patients (7.8%) were previously treated with only radiotherapy, and two patients (3.1 %) had received no prior management and thus were taken to bilateral orchiectomy along with palliative TURP in a single surgical act. With regard to the pathology reports, tumor tissue was found in 50 patients (76%), and no tumor was observed in the remaining 16 patients (24%). In one case (1.5%), the Gleason score (GS) could not be determined due to the effects of orchiectomy. Under-staging in the grade group was evidenced in 23 patients (46.9%), over-staging in three patients (6.3%), and no difference in 23 patients (46.9%), when compared to the initial GS at biopsy. The mortality rate and the incidence of TURP syndrome were low (3.1% and 1.5%, respectively). A 46% reduction in the mean serum prostate-specific antigen (PSA) value was documented when the preoperative and postoperative values were compared. A decrease in the serum PSA levels was observed after palliative TURP, and despite having received ADT, it was possible to determine tumor pathology in the resected tissue, being able to identify a greater grade group compared the GS at the time of diagnosis. The palliative TURP proved to be a safe procedure to relieve LUTS in patients with advanced PCa, with a low morbidity and mortality rate.
- 24 September 2019
- Published by Springer Nature in Cureus
- Vol. 11 (9) , e5740
Open AccessClinical and Histopathological Characteristics of Prostate Cancer Patients Taken to Palliative Transurethral Prostate Resection
In prostate cancer (PCa) patients who have been treated with radiotherapy and/or androgen deprivation therapy (ADT), palliative transurethral resection of the prostate (TURP) is a management option in the presence of lower urinary tract symptoms (LUTS). The present work seeks to describe the clinical and histopathological characteristics of patients with PCa taken to palliative TURP. An observational, descriptive and retrospective study of patients with PCa who underwent palliative TURP for the relief of obstructive urinary symptoms at an oncology reference center between January 2006 and June 2014 was performed. Among the included patients were those with localized PCa treated with radiotherapy and those with advanced PCa with or without metastasis who had previously received ADT. Sixty-six patients with a diagnosis of PCa taken to palliative RTUP were identified. Fifty patients (78.4%) were received some type of ADT, seven patients (10.7%) received curative radiotherapy along with adjuvant ADT, five patients (7.8%) were previously treated with only radiotherapy, and two patients (3.1 %) had received no prior management and thus were taken to bilateral orchiectomy along with palliative TURP in a single surgical act. With regard to the pathology reports, tumor tissue was found in 50 patients (76%), and no tumor was observed in the remaining 16 patients (24%). In one case (1.5%), the Gleason score (GS) could not be determined due to the effects of orchiectomy. Under-staging in the grade group was evidenced in 23 patients (46.9%), over-staging in three patients (6.3%), and no difference in 23 patients (46.9%), when compared to the initial GS at biopsy. The mortality rate and the incidence of TURP syndrome were low (3.1% and 1.5%, respectively). A 46% reduction in the mean serum prostate-specific antigen (PSA) value was documented when the preoperative and postoperative values were compared. A decrease in the serum PSA levels was observed after palliative TURP, and despite having received ADT, it was possible to determine tumor pathology in the resected tissue, being able to identify a greater grade group compared the GS at the time of diagnosis. The palliative TURP proved to be a safe procedure to relieve LUTS in patients with advanced PCa, with a low morbidity and mortality rate.